Luo D, Yu Y, Wang Q, Peng T, et al. The benefit and risk of addition of PD-1/PD-L1 inhibitors to chemotherapy for advanced cervical cancer: a phase 3 randomized controlled trials based meta-analysis. BMC Cancer 2025;25:450.
PMID: 40075324